News from the BioRN Cluster

Home  >>  News from the BioRN Cluster

UK Biobank partners with the EGA

On Juli 21, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für UK Biobank partners with the EGA

Genetic data from the UK Biobank’s major cohort is now distributed through the European Genome–phenome Archive (EGA), ensuring its sustainable, secure delivery to approved biomedical researchers worldwide. Genomic data from the 500,000 people participating in the UK Biobank initiative will be distributed via the European Genome–phenome Archive (EGA), a resource…

DKFZ: Surprising genetic variety in childhood brain cancer

On Juli 20, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: Surprising genetic variety in childhood brain cancer

An international research team led by scientists from the German Cancer Research Center (DKFZ) and the Hopp Children’s Tumor Center at the NCT Heidelberg (KiTZ) has identified new genetic alterations and mechanisms that lead to very aggressive types of childhood brain cancer. Their results, which have now been published in…

Dynamic PERMIDES Matchmaking Event in Heidelberg

On Juli 18, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Dynamic PERMIDES Matchmaking Event in Heidelberg

Heidelberg, July 12th 2017 Thirty-three European SMEs gathered in Heidelberg’s Technologiepark this week for a compact and highly efficient PERMIDES Matchmaking Lunch. Biopharma, bioinformatics and IT companies from 12 European countries gave 1-min pitches introducing their company, core expertise and needs to attract the right partners for the 1:1-matchmaking part…

Young Investigator Award for DKFZ researcher

On Juli 18, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Young Investigator Award for DKFZ researcher

For his work towards developing a vaccine against brain tumors, Lukas Bunse from the German Cancer Research Center (DKFZ) has received the Young Investigator Award of the 2017 Württemberg Cancer Award. The award comes with a budget of €15,000. Lukas Bunse © DKFZ Tumor cells often exhibit gene mutations that…

DKFZ: How blood vessels slow down and accelerate tumor growth

On Juli 18, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: How blood vessels slow down and accelerate tumor growth

Scientists from the German Cancer Research Center (DKFZ) and Heidelberg University have discovered a new mechanism that causes faster sprouting of blood vessels. Cells of a specific type called pericytes, which are attached to the outside of fine blood vessels, are involved in this process. If a particular protein molecule…

Technologiepark Heidelberg: Land fördert Startup-Programme mit 2,1 Millionen Euro

On Juli 17, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Technologiepark Heidelberg: Land fördert Startup-Programme mit 2,1 Millionen Euro

Stuttgart, 14. Juli 2017 – Im Rahmen des Startup-Gipfels in Stuttgart konnten die Projektpartner der Startup-Programme Life Science Accelerator und Up2B einen Förderbescheid über 2,1 Millionen Euro entgegennehmen. Mit der Förderung von insgesamt sechs innovativen Vorhaben gaben Ministerpräsident Winfried Kretschmann (Grüne) und Wirtschaftsministerin Nicole Hoffmeister-Kraut (CDU) den Startschuss für die neue Gründungsoffensive…

Roche’s OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia

On Juli 17, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Roche’s OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia

Second approval after the US for OCREVUS as the first and only approved treatment for people with primary progressive multiple sclerosis, a highly disabling form of MS Australia has among the highest prevalence of MS in the Southern Hemisphere1 Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that OCREVUS® (ocrelizumab)…

European Health Catapult: On a cruise with 19 innovative start-ups for new solutions in healthy living and active ageing

On Juli 13, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für European Health Catapult: On a cruise with 19 innovative start-ups for new solutions in healthy living and active ageing

Regional Selection Event for European Health Catapult in Heidelberg   On 11 July 2017, EIT Health Germany together with BioRN organized the second edition of the SHIP – Ship for Health Innovation Pitches in Heidelberg. The aim of the event was to select the best healthcare start-ups in the categories…

TU Kaiserslautern: 5,4 Millionen Euro jährlich durch die Forschungsinitiative Rheinland-Pfalz

On Juli 13, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für TU Kaiserslautern: 5,4 Millionen Euro jährlich durch die Forschungsinitiative Rheinland-Pfalz

Der rheinland-pfälzische Wissenschaftsminister Konrad Wolf hat heute gemeinsam mit den Präsidenten der Universitäten und Hochschulen des Landes die Zielvereinbarung zur Weiterführung der „Forschungsinitiative Rheinland-Pfalz“ bis 2018 unterzeichnet. Auch die TU Kaiserslautern wird von dieser nächsten Förderphase mit jährlich 5,4 Millionen Euro profitieren. Mit dem Geld soll die Forschung weiter gestärkt…

New name for EMBL’s site in Italy

On Juli 13, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für New name for EMBL’s site in Italy

EMBL’s unit in Italy is changing name to reflect better its new research focuses and highlight its location for EMBL’s international audience. EMBL’s unit in Italy is changing name to reflect better its new research focuses and highlight its location for EMBL’s international audience. It is now the: Epigenetics and…

Phenex AG announces milestone payment from Janssen for the entry of RORgt inhibitor into Phase I

On Juli 10, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Phenex AG announces milestone payment from Janssen for the entry of RORgt inhibitor into Phase I

Phenex AG announces milestone payment from Janssen for the entry of RORgt inhibitor into Phase I Phenex drug discovery has now resulted in two clinical stage programs this year through research collaborations Ludwigshafen, Germany, July 10, 2017 Phenex Pharmaceuticals AG (Phenex) today announced the achievement of a milestone in the…

Fraunhofer IGB: Mehr Raum für angewandte Forschung

On Juli 7, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Fraunhofer IGB: Mehr Raum für angewandte Forschung

Mehr Raum für angewandte Forschung Fraunhofer Presseinformation / 7.7.2017 Anfang des Jahres wurde in Stuttgart-Vaihingen ein neues Technikumgebäude für die Fraunhofer-Institute IGB und IPA in Betrieb genommen. Der Neubau beherbergt Labore, Versuchsfelder und Technika in den Themenfeldern Robotik, Ressourceneffizienz und Laborautomatisierung, Lebensmittel- und Medizintechnik sowie Wasseraufbereitung. Damit steht dem Standort…

Merck Biopharma Innovation Cup 2017 – Announcement of the winning team

On Juli 6, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Merck Biopharma Innovation Cup 2017 – Announcement of the winning team

Merck, a leading science and technology company, today announced the winners of its seventh Biopharma Innovation Cup. The winning team received €20,000 for its innovative idea around the role of Natural Killer. 06 JUL 2017 | Darmstadt, Germany Winning team receives €20,000 for innovative project proposal on the role of…

Merck Awards €1.25 Million to Research Projects Through its 2017 Grant for Fertility Innovation (GFI)

On Juli 6, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Merck Awards €1.25 Million to Research Projects Through its 2017 Grant for Fertility Innovation (GFI)

Merck today announced its commitment to award €1.25 million to research projects in the field of fertility, supporting the advancement of medical science through the Grant for Fertility Innovation (GFI) in 2017 05 JUL 2017 | Darmstadt, Germany Two projects are awarded funds to advance the fertility field Professor Lunenfeld…

Technology Park: Schneller Gründen in Baden-Württemberg: Förderzusage für Life Science Accelerator BW

On Juli 4, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Technology Park: Schneller Gründen in Baden-Württemberg: Förderzusage für Life Science Accelerator BW

Life Science Accelerator BW erhält Förderzusage vom Europäischen Sozialfonds und Ministerium für Wirtschaft, Arbeit und Wohnungsbau Baden-Württemberg. Der Accelerator unterstützt in Baden-Württemberg wissenschaftliche und technologische Startups und entstand durch das gemeinsame Engagement der Technologiepark Heidelberg GmbH als Gründungsmitglied des Heidelberg Startups Partners e.V., der Wirtschafts- und Strukturförderung der Stadt Mannheim…

Fraunhofer IGB: »Innovatoren unter 35«: Dr. Svenja Hinderer erhält Innovationspreis

On Juli 4, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Fraunhofer IGB: »Innovatoren unter 35«: Dr. Svenja Hinderer erhält Innovationspreis

Seit vier Jahren zeichnet das Innovationsmagazin »Technology Review« herausragende Nachwuchsforscherinnen und -forscher in Deutschland aus. In diesem Jahr wählte die Jury nun auch Dr. Svenja Hinderer in den Kreis der zehn »Innovatoren unter 35«. Die Chemikerin entwickelt am Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB in Stuttgart ein neuartiges künstliches Herzklappenmaterial,…

Roche: Roche acquires mySugr to form a leading open platform for digital diabetes management

On Juni 30, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Roche: Roche acquires mySugr to form a leading open platform for digital diabetes management

mySugr will become an integral part of Roche’s new patient-centred digital health services in diabetes care   Healthcare providers can continue to utilise existing Accu-Chek tools to make better and faster therapy decisions while improving communication with their patients The open platform for advanced data sharing capabilities and coaching services connects…

DKFZ: €5.7 million for novel treatment approaches in pediatric brain cancer

On Juni 30, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: €5.7 million for novel treatment approaches in pediatric brain cancer

Children with low grade brain cancer usually suffer many years of distress. An international initiative that is coordinated at the German Cancer Research Center (DKFZ) and the Hopp Children’s Tumor Center (KiTZ) at the National Center for Tumor Diseases (NCT) Heidelberg has now been established with the goal of changing…

DKFZ: Double imaging of prostate cancer

On Juni 30, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: Double imaging of prostate cancer

Scientists from the German Cancer Research Center (DKFZ) are developing a radiopharmaceutical that visualizes prostate cancer in two different ways: Radioactive labeling facilitates detection of a tumor or its metastases in the body. At the same time, a coupled fluorescent dye helps surgeons identify and safely remove cancer tissue during…

DKFZ: Double imaging of prostate cancer

On Juni 28, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: Double imaging of prostate cancer

Scientists from the German Cancer Research Center (DKFZ) are developing a radiopharmaceutical that visualizes prostate cancer in two different ways: Radioactive labeling facilitates detection of a tumor or its metastases in the body. At the same time, a coupled fluorescent dye helps The so-called bimodal radiopharmaceutical binds to prostate-specific membrane…